Cargando…
Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor
BACKGROUND: There are several genes associated with ovarian cancer risk. Molecular changes in borderline ovarian tumor (BOT) indicate linkage of this disease to type I ovarian tumors (low-grade ovarian carcinomas). This study determined the prevalence and association of mutations in BRCA1, BRCA2, PA...
Autores principales: | Ogrodniczak, Alicja, Menkiszak, Janusz, Gronwald, Jacek, Tomiczek-Szwiec, Joanna, Szwiec, Marek, Cybulski, Cezary, Dębniak, Tadeusz, Huzarski, Tomasz, Tołoczko-Grabarek, Aleksandra, Byrski, Tomasz, Białkowska, Katarzyna, Prajzendanc, Karolina, Baszuk, Piotr, Lubiński, Jan, Jakubowska, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935754/ https://www.ncbi.nlm.nih.gov/pubmed/35313928 http://dx.doi.org/10.1186/s13053-022-00218-0 |
Ejemplares similares
-
Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer
por: Łukomska, Alicja, et al.
Publicado: (2021) -
The risk of breast cancer in women with a CHEK2 mutation
por: Cybulski, Cezary, et al.
Publicado: (2012) -
Folic acid and cancer risk in BRCA1 carriers
por: Durda, Katarzyna, et al.
Publicado: (2012) -
CHEK2 mutations as markers for high risk of breast cancer
por: Cybulski, Cezary, et al.
Publicado: (2012) -
Serum concentration of iron as predictor of cancer risk among BRCA1 mutation carriers
por: Sukiennicki, Grzegorz, et al.
Publicado: (2012)